Strategy Asset Managers’s Allergan plc AGN Stock Holding History

Strategy Asset Managers’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-12,924	Closed	-$4.04M	–	165
2015 Q4	$4.04M	Buy	12,924 +36	+0.3%	+$10.7K	0.92%	35
2015 Q3	$3.5M	Sell	12,888 -32	-0.2%	-$9.83K	0.84%	35
2015 Q2	$3.92M	Sell	12,920 -108	-0.8%	-$32.2K	0.87%	33
2015 Q1	$3.88M	Sell	13,028 -6	-0%	-$1.71K	0.85%	33
2014 Q4	$3.35M	Sell	13,034 -25	-0.2%	-$6.25K	0.71%	44
2014 Q3	$3.15M	Buy	+13,059	New	+$2.92M	0.69%	40

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Strategy Asset Managers's AGN Position: Q1 2016 in Review

Strategy Asset Managers sold out of Allergan plc (AGN) in Q1 2016, closing a stake of 12,924 shares — an estimated $4.04M sold.

Strategy Asset Managers first reported a position in AGN in Q3 2014 and held it in 6 quarters. The position peaked at $4.04M in Q4 2015. 1,119 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

Strategy Asset Managers reported no remaining Allergan plc position as of Q1 2016 after selling out during the quarter.
Strategy Asset Managers sold 12,924 Allergan plc shares in Q1 2016, an estimated $4.04M.
Strategy Asset Managers first reported a position in Allergan plc in Q3 2014 and held it in 6 quarters.
Strategy Asset Managers's Allergan plc position peaked at $4.04M in Q4 2015.
1,119 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on Strategy Asset Managers's 13F filing for Q1 2016, filed 29 Apr 2016.